Late-Breaking Abstracts
The ASCO Late-Breaking Abstracts Policy allows for the submission of Late-Breaking Abstracts only for randomized phase III trials for which no preliminary data are available at the time of the abstract submission deadline (February 1, 2012), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before April 2, 2012 (deadline for the final, updated Late-Breaking Abstract). During abstract submission, you will be required to provide the date of planned analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline.